New Drug for Dialysis-related Itching
Itching is a form of pain, and dialysis-related itching affects up to 40% of people on dialysis—with no approved treatment. Vifor Pharma and Cara Therapeutics have signed a licensing agreement to bring Korsuva (difelikefalin) injections to the market.
Read the full article » | Posted 11-12-2020
Related Articles
- Kamal Shah of NephroPlus Discusses Dalysis Innovations Posted 08-16-2024
- Global Wearable Artificial Kidney Market Expected to Grow Posted 07-12-2024
- Byonyks X1: a New, Small, Portable APD Machine Posted 06-14-2024
- The Public-Private ASN, DHSS, KidneyX Partnership is 5 Years Old This Year Posted 05-09-2024